282 related articles for article (PubMed ID: 21211030)
1. Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression.
Javelaud D; van Kempen L; Alexaki VI; Le Scolan E; Luo K; Mauviel A
Mol Cancer; 2011 Jan; 10(1):2. PubMed ID: 21211030
[TBL] [Abstract][Full Text] [Related]
2. SKI knockdown inhibits human melanoma tumor growth in vivo.
Chen D; Lin Q; Box N; Roop D; Ishii S; Matsuzaki K; Fan T; Hornyak TJ; Reed JA; Stavnezer E; Timchenko NA; Medrano EE
Pigment Cell Melanoma Res; 2009 Dec; 22(6):761-72. PubMed ID: 19845874
[TBL] [Abstract][Full Text] [Related]
3. Repression of TGF-beta signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis.
Medrano EE
Oncogene; 2003 May; 22(20):3123-9. PubMed ID: 12793438
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-beta resistance, in primary cutaneous melanoma.
Boone B; Haspeslagh M; Brochez L
J Dermatol Sci; 2009 Jan; 53(1):26-33. PubMed ID: 18782659
[TBL] [Abstract][Full Text] [Related]
5. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
He J; Tegen SB; Krawitz AR; Martin GS; Luo K
J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
[TBL] [Abstract][Full Text] [Related]
6. Influence of melanoma inhibitory activity on transforming growth factor-beta signaling in malignant melanoma.
Rothhammer T; Bosserhoff AK
Melanoma Res; 2006 Aug; 16(4):309-16. PubMed ID: 16845326
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma.
Fukuchi M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Sohda M; Manda R; Tsukada K; Kato H; Kuwano H
Int J Cancer; 2004 Mar; 108(6):818-24. PubMed ID: 14712482
[TBL] [Abstract][Full Text] [Related]
8. Actin-cytoskeleton polymerization differentially controls the stability of Ski and SnoN co-repressors in normal but not in transformed hepatocytes.
Caligaris C; Vázquez-Victorio G; Sosa-Garrocho M; Ríos-López DG; Marín-Hernández A; Macías-Silva M
Biochim Biophys Acta; 2015 Sep; 1850(9):1832-41. PubMed ID: 26002202
[TBL] [Abstract][Full Text] [Related]
9. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration.
Macias-Silva M; Li W; Leu JI; Crissey MA; Taub R
J Biol Chem; 2002 Aug; 277(32):28483-90. PubMed ID: 12023281
[TBL] [Abstract][Full Text] [Related]
10. Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer.
Heider TR; Lyman S; Schoonhoven R; Behrns KE
Ann Surg; 2007 Jul; 246(1):61-8. PubMed ID: 17592292
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling.
Reed JA; Bales E; Xu W; Okan NA; Bandyopadhyay D; Medrano EE
Cancer Res; 2001 Nov; 61(22):8074-8. PubMed ID: 11719430
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling.
Yang J; Zhang X; Li Y; Liu Y
J Am Soc Nephrol; 2003 Dec; 14(12):3167-77. PubMed ID: 14638915
[TBL] [Abstract][Full Text] [Related]
13. Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling.
Nagano Y; Mavrakis KJ; Lee KL; Fujii T; Koinuma D; Sase H; Yuki K; Isogaya K; Saitoh M; Imamura T; Episkopou V; Miyazono K; Miyazawa K
J Biol Chem; 2007 Jul; 282(28):20492-501. PubMed ID: 17510063
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression.
Luo DD; Phillips A; Fraser D
Am J Pathol; 2010 Mar; 176(3):1139-47. PubMed ID: 20093492
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.
Krakowski AR; Laboureau J; Mauviel A; Bissell MJ; Luo K
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12437-42. PubMed ID: 16109768
[TBL] [Abstract][Full Text] [Related]
16. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
Zhu Q; Pearson-White S; Luo K
Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4.
Tecalco-Cruz AC; Sosa-Garrocho M; Vázquez-Victorio G; Ortiz-García L; Domínguez-Hüttinger E; Macías-Silva M
J Biol Chem; 2012 Aug; 287(32):26764-76. PubMed ID: 22674574
[TBL] [Abstract][Full Text] [Related]
18. Clinical markers and driving mechanisms in melanoma progression: VEGF-C, RhoC, c-Ski/SnoN and EGFR.
Boone B; Brochez L
Verh K Acad Geneeskd Belg; 2009; 71(5):251-94. PubMed ID: 20232784
[TBL] [Abstract][Full Text] [Related]
19. Context-dependent regulation of the expression of c-Ski protein by Arkadia in human cancer cells.
Nagano Y; Koinuma D; Miyazawa K; Miyazono K
J Biochem; 2010 Apr; 147(4):545-54. PubMed ID: 19959502
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta repressors SnoN and Ski are implicated in human colorectal carcinogenesis.
Bravou V; Antonacopoulou A; Papadaki H; Floratou K; Stavropoulos M; Episkopou V; Petropoulou C; Kalofonos H
Cell Oncol; 2009; 31(1):41-51. PubMed ID: 19096149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
